Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for malignant bowel obstruction in advanced cancer
ACTRN12608000211369Phase 3Completed
- Sponsor
- Flinders University
- Start
- Aug 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bowel obstruction comparing Octreotide combination arm with Placebo control arm (2 arms). Primary endpoint: Days without vomiting. Started Aug 2008; status: completed.
02
Drugs
octreotide
03
Conditions
bowel obstruction
Beyond the preview
Go deeper on ACTRN12608000211369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000211369.